Zdrowie i gospodarka · 17/11/2014
FDA Announces Draft Guidance for Rare Pediatric Disease Priority Review Vouchers
The FDA is releasing a draft guidance outlining the criteria for awarding priority review vouchers to sponsors of rare pediatric disease product applications, aiming to encourage development of new treatments for rare pediatric diseases.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →